Purple Biotech
PPBT
16 hedge funds and large institutions have $75.9K invested in Purple Biotech in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
177% more capital inflows, than outflows
Capital inflows: $198K | Capital outflows: $71.5K
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
14% more funds holding
Funds holding: 14 → 16 (+2)
0.69% less ownership
Funds ownership: 2.16% → 1.47% (-0.69%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Virtu Financial
New York
|
+$87.8K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$74K |
| 3 |
GAMMA Investing
Foster City,
California
|
+$14.7K |
| 4 |
Morgan Stanley
New York
|
+$11.7K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$8.97K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Kingswood Wealth Advisors
San Diego,
California
|
-$39.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$30.8K |
| 3 |
Raymond James Financial
St Petersburg,
Florida
|
-$1.3K |
PPBT Hedge Fund Activity: Q3 2025 in Review
16 of the 7,661 institutional investors tracked by Wall St. Rank reported a position in Purple Biotech (PPBT) for Q3 2025, worth a combined $75.9K — down 43% from $134K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new PPBT positions and 2 closed out — a net gain of 2 holders — while 5 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $87.8K. The largest seller was Kingswood Wealth Advisors, exiting entirely with an estimated $39.4K sold.
- 16 institutional investors held Purple Biotech (PPBT) as of Q3 2025, up from 14 in Q2 2025.
- Funds reported $75.9K of Purple Biotech stock for Q3 2025, down 43% quarter-over-quarter.
- 4 funds opened new Purple Biotech positions in Q3 2025 and 2 closed out, a net change of +2 holders.
- The largest Purple Biotech buyer in Q3 2025 was Virtu Financial, an estimated $87.8K added.
- The largest Purple Biotech seller in Q3 2025 was Kingswood Wealth Advisors, an estimated $39.4K sold.
Based on aggregated 13F filings for Q3 2025.